India crosses ‘200 Crore’ COVID-19 vaccinations
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Novavax’ clinical development program reported no severe allergic reactions
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Company is investing more than €100 million in the expansion of the Halle site
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
The vaccine is under FDA review
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
It is a two dose vaccine to be administered intramuscularly at 28 days apart
Subscribe To Our Newsletter & Stay Updated